These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 17899368

  • 1. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
    Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, Pernak M, Litwiniuk M, Nowak J.
    Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
    [Abstract] [Full Text] [Related]

  • 2. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
    Nowak J, Mosor M, Ziółkowska I, Wierzbicka M, Pernak-Schwarz M, Przyborska M, Roznowski K, Pławski A, Słomski R, Januszkiewicz D.
    Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
    [Abstract] [Full Text] [Related]

  • 3. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E, Jarolim P, Seeman P, Varon R, Digweed M, Swift M, Sperling K.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1875-80. PubMed ID: 18073374
    [Abstract] [Full Text] [Related]

  • 4. NBS1 variant I171V and breast cancer risk.
    Bogdanova N, Schürmann P, Waltes R, Feshchenko S, Zalutsky IV, Bremer M, Dörk T.
    Breast Cancer Res Treat; 2008 Nov 19; 112(1):75-9. PubMed ID: 18049891
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.
    Huang J, Grotzer MA, Watanabe T, Hewer E, Pietsch T, Rutkowski S, Ohgaki H.
    Clin Cancer Res; 2008 Jul 01; 14(13):4053-8. PubMed ID: 18593981
    [Abstract] [Full Text] [Related]

  • 9. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
    Watanabe T, Nobusawa S, Lu S, Huang J, Mittelbronn M, Ohgaki H.
    J Neuropathol Exp Neurol; 2009 Feb 01; 68(2):210-5. PubMed ID: 19151620
    [Abstract] [Full Text] [Related]

  • 10. [Mutations in tumor suppressor gene NBS1 in adult patients with malignancies].
    Seemanová E, Hoch J, Herzogová J, Kawaciuk I, Janda J, Kohoutová M, Seeman P, Varon R, Sperling K.
    Cas Lek Cesk; 2006 Feb 01; 145(3):201-3. PubMed ID: 16634478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
    Steffen J, Nowakowska D, Niwińska A, Czapczak D, Kluska A, Piatkowska M, Wiśniewska A, Paszko Z.
    Int J Cancer; 2006 Jul 15; 119(2):472-5. PubMed ID: 16770759
    [Abstract] [Full Text] [Related]

  • 15. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
    Bogdanova N, Feshchenko S, Schürmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dörk T.
    Int J Cancer; 2008 Feb 15; 122(4):802-6. PubMed ID: 17957789
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Increased risk of malignancies in heterozygotes in families of patients with Nijmegen breakage syndrome].
    Seemanová E, Jarolím P, Seeman P, Varon R, Sperling K.
    Cas Lek Cesk; 2006 Feb 15; 145(2):138-43. PubMed ID: 16521404
    [Abstract] [Full Text] [Related]

  • 19. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
    Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, Demkow T, Sadowska M, Bidziński M, Gawrychowski K, Sperling K.
    Int J Cancer; 2004 Aug 10; 111(1):67-71. PubMed ID: 15185344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.